RKDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Arcadia Biosciences Inc (RKDA) is not a good buy at the moment for a beginner investor with a long-term strategy. The company's financial performance is weak, with significant declines in revenue, net income, and EPS. There are no positive trading trends, news catalysts, or strong technical signals to suggest an immediate buying opportunity. Additionally, no proprietary trading signals from Intellectia or significant insider or hedge fund activity support a buy decision.
The technical indicators are neutral. The MACD is slightly positive but contracting, RSI is neutral at 39.073, and moving averages are converging. The stock is trading near its key support level (S1: 1.789), but there is no clear bullish signal.
NULL identified. No recent news or significant trading activity from insiders or hedge funds.
Weak financial performance in Q3 2025, with revenue down 15.29% YoY, net income down 153.10% YoY, and EPS down 152.54% YoY. Gross margin also declined by 25.14%. Broader market sentiment is negative, with the S&P 500 down 1.03%.
The company reported a significant decline in financial metrics for Q3 2025. Revenue dropped to $1,302,000 (-15.29% YoY), net income dropped to $856,000 (-153.10% YoY), EPS dropped to 0.62 (-152.54% YoY), and gross margin fell to 32.1 (-25.14% YoY).
No recent analyst rating or price target changes available.
